IP Library › Granted Patent US 9,174,992
Granted Patent B2
US 9,174,992 · App. 13/780,557 · Granted Nov 3, 2015

Heterobicyclic compounds

Inventors: Jennifer R. Allen (Newbury Park, CA); Albert Amegadzie (Moorpark, CA); Kristin L. Andrews (Thousand Oaks, CA); James Brown (Moorpark, CA); Jian J. Chen (Camarillo, CA); Ning Chen (Thousand Oaks, CA); Essa Hu Harrington (Camarillo, CA); Qingyian Liu (Camarillo, CA); Thomas T. Nguyen (Newbury Park, CA); Alexander J. Pickrell (Westlake Village, CA); Wenyuan Qian (Camarillo, CA); Shannon Rumfelt (Camarillo, CA); Robert M. Rzasa (Ventura, CA); Chester Chenguang Yuan (Newbury Park, CA); Wenge Zhong (Thousand Oaks, CA)
Assignee: Amgen Inc.
C07D487/04C07D417/12C07D471/04C07D473/00C07D473/30C07D473/34C07D473/40C07D498/04C07D513/04C07D519/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,174,992
App. No.
13/780,557
Granted
Nov 3, 2015
Kind
B2
Abstract

Heterobicyclic compounds of Formula (I): or a pharmaceutically-acceptable salt, tautomer, or stereoisomer thereof, as defined in the specification, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, Huntington's Disease, and the like.

Claims (172)

1. A compound of Formula (I):

or a pharmaceutically-acceptable salt, tautomer, or stereoisomer thereof, wherein:

each p and q is independently 1; wherein the sum of p and q is 2;

m is 0, 1, 2, 3, or 4;

A is a 9- to 10-membered heterocyclic ring having the formula:

wherein the group —W-T-D< is selected from the group consisting of: —N═CR 5 —N<; NR 7 —N═C<; —NR 7 —(C═O)—N<; NR 7 —CR 6 R 7 —(C═O)—N<; —NR 7 —(SO 2 )—N<; —CR 5 ═CR 5 —N<; —CR 8 ═N—N<; —CR 6 R 7 —(C═O)—N<; —CR 6 R 7 —NR 7 —(C═O)—N<; —CR 6 R 7 —O—(C═O)—N<; —CR 6 R 7 —(SO 2 )—N<; —O—(C═O)—N<; and —O—CR 6 R 7 —(C═O)—N<;

J is CR 3c ; wherein each E, X, Y, and Z is independently N or CR 4 ; wherein 1, 2, or 3 of E, X, Y, and Z are N;

G is R 1 , —NR 1 R 2 ; —NH(C═O)R 1 ; —OR 1 , —(C═O)R 1 ; or —CHR 1 R 2 ;

R 1 is a carbon-linked or nitrogen-linked saturated, partially-saturated or unsaturated 9- or 10-membered bicyclic ring, wherein each said ring contains 0, 1, 2, 3, or 4 N atoms and 0, 1, or 2 O or S atoms; wherein each R 1 is independently substituted by 0, 1, 2 or 3 R 9 groups;

R 2 is independently H, OH, C 1-4 alk, a carbon-linked or nitrogen-linked saturated, partially-saturated, or unsaturated 5- or 6-membered monocyclic ring, wherein each said ring contains 0, 1, 2, 3, or 4 N atoms and 0, 1, or 2 O or S atoms; wherein each R 2 C 1-4 alk or monocyclic ring is independently substituted by 0, 1, 2 or 3 R 9 groups;

each R 3a and R 3c is independently H, F, OH, C 1-4 alk, or C 1-4 haloalk;

R 3b is independently F, Cl, Br, CN, OH, OC 1-4 alk, C 1-4 alk, C 1-4 haloalk, or oxo;

R 4 is halo, R 4a , —SR 4a , —OR 4a , —NHR 4a , or —N(C 1-4 alk)R 4a , wherein —R 4a is H, C 1-4 alk, a saturated, partially-saturated or unsaturated 3-, 4-, 5- or 6-membered monocyclic ring, wherein each said ring contains 0, 1, 2, 3, or 4 N atoms and 0, 1, or 2 O or S atoms; wherein each R 4 C 1-4 alk or monocyclic ring is independently substituted by 0, 1, 2 or 3 R 9 groups;

each R 5 is independently R 5a , —OR 5b , —NHR 5a , or —N(C 1-4 alk)R 5a , wherein R 5a is H or C 1-4 alk; R 5b is C 1-4 alk, a saturated, partially-saturated or unsaturated 3-, 4-, 5- or 6-membered monocyclic ring, wherein each said ring contains 0, 1, 2, 3, or 4 N atoms and 0, 1, or 2 O or S atoms; wherein each R 5 C 1-4 alk or monocyclic ring is independently substituted by 0, 1, 2 or 3 R 9 groups;

each R 6 and R 7 is independently H, halo, OH, C 1-4 alk, OC 1-4 alk, a saturated, partially-saturated or unsaturated 3-, 4-, 5- or 6-membered monocyclic ring, wherein each said ring contains 0, 1, 2, 3, or 4 N atoms and 0, 1, or 2 O or S atoms; wherein each R 6 and R 7 C 1-4 alk or monocyclic ring is independently substituted by 0, 1, 2 or 3 R 9 groups;

or R 6 and R 7 may optionally form a saturated or partially-saturated 3-, 4-, 5- or 6-membered monocyclic ring, wherein each said ring contains 0, 1, 2, 3, or 4 N atoms and 0, 1, or 2 O or S atoms; wherein said monocyclic ring is independently substituted by 0, 1, 2 or 3 R 9 groups;

R 8 is R 8a , —O—R 8a , —NHR 8a , or —N(C 1-4 alk)R 8a , wherein R 8a is H, C 1-4 alk, a saturated, partially-saturated or unsaturated 3-, 4-, 5- or 6-membered monocyclic ring, wherein each said ring contains 0, 1, 2, 3, or 4 N atoms and 0, 1, or 2 O or S atoms; wherein each R 8 C 1-4 alk or monocyclic ring is independently substituted by 0, 1, 2 or 3 R 9 groups;

R 9 is independently F, Cl, Br, C 1-6 alk, C 1-4 haloalk, —OR a , OR c , —OC 1-4 haloalk, CN, —C(═O)R b , —C(═O)R c , —C(═O)OR a , —C(═O)NR a R a , —C(═O)NR a R c , —C(═NR a )NR a R a , —OC(═O)R b , —OC(═O)NR a R a , —OC 1-6 alkNR a R a , —OC 1-6 alkOR a , —SR a , —S(═O)R b , —S(═O) 2 R b , —S(═O) 2 NR a R a , —NR a R a , —N(R a )C(═O)R b , —N(R a )C(═O)OR b , —N(R a )C(═O)NR a R a , —N(R a )C(═NR a )NR a R a , —N(R a )S(═O) 2 R b , —N(R a )S(═O) 2 NR a R a , —NR a C 1-6 alkNR a R a , —NR a C 1-6 alkOR a , —C 1-6 alkNR a R a , —C 1-6 alkOR a , —C 1-6 alkN(R a )C(═O)R b , —C 1-6 alkOC(═O)R b , —C 1-6 alkC(═O)NR a R a , —C 1-6 alkC(═O)OR a , or oxo;

R 10 is halo, C 1-6 alk, C 1-4 haloalk, —OR a , —OC 1-4 haloalk, CN, —C(═O)R b , —C(═O)OR a , —C(═O)NR a R a , —C(═NR a )NR a R a , —OC(═O)R b , —OC(═O)NR a R a , —OC 1-6 alkNR a R a , —OC 1-6 alkOR a , —SR a , —S(═O)R b , —S(═O) 2 R b , —S(═O) 2 NR a R a , —NR a R a , —N(R a )C(═O)R b , —N(R a )C(═O)OR b , —N(R a )C(═O)NR a R a , —N(R a )C(═NR a )NR a R a , —N(R a )S(═O) 2 R b , —N(R a )S(═O) 2 NR a R a , —NR a C 1-6 alkNR a R a , —NR a C 1-6 alkOR a , —C 1-6 alkNR a R a , —C 1-6 alkOR a , —C 1-6 alkN(R a )C(═O)R b , —C 1-6 alkOC(═O)R b , —C 1-6 alkC(═O))NR a R a , —C 1-6 alkC(═O)OR a , or oxo;

R a is independently H or R b ;

R b is independently phenyl, benzyl, or C 1-6 alk, wherein said phenyl, benzyl, and C 1-6 alk are substituted by 0, 1, 2 or 3 substituents which are C 1-4 alk, C 1-3 haloalk, —OH, —OC 1-4 alk, —NH 2 , —NHC 1-4 alk, —OC(═O)C 1-4 alk, or —N(C 1-4 alk)C 1-4 alk; and

R c is independently a carbon-linked or nitrogen-linked saturated, partially-saturated or unsaturated 3-, 4-, 5-, 6-, or 7-membered monocyclic ring or a saturated, partially-saturated or unsaturated 6-, 7-, 8-, 9-, 10-, 11-, or 12-membered bicyclic ring, said ring contains 0, 1, 2, 3, or 4 N atoms and 0, 1, or 2 atoms which are O or S; R c is independently substituted by 0, 1, 2 or 3 R 10 groups.

2. The compound as in claim 1 wherein the group

3. The compound as in claim 1 wherein E, X, Y, and Z is independently N or CR 4 ; wherein 1 or 2 of E, X, Y, and Z are N; selected from the group consisting of

4. The compound as in claim 1 wherein the group —W-T-D<is selected from the group consisting of —N═CR 5 —N<; NR 7 —N═C<; NR 7 —(C═O)—N<; NR 7 —CR 6 R 7 —(C═O)—N<; and —NR 7 —(SO 2 )—N<.

5. The compound as in claim 1 wherein the group —W-T-D<is —NR 7 —(C═O)—N<.

6. The compound as in claim 5 wherein R 7 is H, C 1-4 alk or a saturated 3-, 4-, 5- or 6-membered monocyclic ring; or unsaturated 5- or 6-membered monocyclic ring; wherein each said ring contains 0, 1, or 2 N atoms and 0, 1, or 2 O or S atoms; wherein said R 7 C 1-4 alk or monocyclic ring is independently substituted by 0, 1, 2 or 3 R 9 groups.

7. The compound as in claim 1 wherein the sum of p and q is 2.

8. The compound as in claim 1 wherein R 1 is a saturated, partially-saturated or unsaturated 9- or 10-membered bicyclic ring wherein each R 1 is selected from

and wherein each R 1 is independently substituted by 0, 1, 2 or 3 R 9 groups.

9. The compound as in claim 1 wherein R 1 is unsaturated 9- or 10-membered bicyclic ring, wherein each said ring contains 0, 1, 2, 3, or 4 N atoms and 0, 1, or 2 O or S atoms; wherein each R 1 is independently substituted by 0, 1, 2 or 3 R 9 groups.

10. The compound as in claim 1 wherein R 1 is pyridothiazolyl, pyridooxazolyl, pyridimidazolyl, pyrazimidazolyl, pyrimidimidazolyl, benzimidazolyl, benzoxazolyl, benzthiazolyl, quinolinyl, isoquinolinyl, quinazolinyl, quinaxolinyl, naphthyridinyl, pyridimidazolyl, pyridopyrazolyl, or thiazolo[5,4-b]pyridinyl.

11. The compound as in claim 1 wherein R 1 is benzoxazolyl, quinazolinyl, quinolinyl, benzimidazolyl, benzthiazolyl, 1,5-naphthyridinyl, 1,6-naphthyridinyl, 1,7-naphthyridinyl, or 1,8-naphthyridinyl.

12. The compound as in claim 1 wherein R 2 is H or methyl.

13. The compound as in claim 1 wherein m is 0.

14. The compound as in claim 1 wherein each R 3a and R 3c is H and m is 0.

15. The compound as in claim 1 wherein J is —CH or —CCH 3 ; and G is R 1 or —NR 1 R 2 .

16. A pharmaceutical composition comprising a compound, or a pharmaceutically-acceptable salt, tautomer, or stereoisomer thereof, as in claim 1 and a pharmaceutically-acceptable excipient.

17. The compound, or a pharmaceutically-acceptable salt thereof, as in claim 1 , selected from the group consisting of:

N-(trans-3-(2-ethyl-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)benzo[d]thiazol-2-amine;

N-(trans-3-(2-cyclopropyl-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)benzo[d]thiazol-2-amine;

N-(Trans-3-(2-cyclopropyl-3h-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)-1,5-naphthyridin-2-amine;

N-(Trans-3-(2-cyclopropyl-3h-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)thiazolo[5,4-b]pyridin -2-amine;

N-(Trans-3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)benzo[d]thiazol-2-amine;

N-(Trans-3-(2-cyclopropyl-3h-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)quinolin-2-amine;

N-(Trans-3-(2-cyclopropyl-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)-6-fluoroquinolin-2-amine;

N-(Trans-3-(2-cyclopropyl-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)quinazolin-2-amine;

N-(Cis-3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)benzo[d]thiazol-2-amine;

N-(trans-3-(2-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)benzo[d]thiazol-2-amine;

N-(Trans-3-(2-cyclopropyl-3h-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)-1,8-naphthyridin-2-amine;

N-(Trans-3-(2-(trifluoromethyl)-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)quinazolin-2-amine;

N-(trans-3-(8-cyclopropyl-9H-purin-9-yl)cyclobutyl)quinazolin-2-amine;

N-(trans-3-(3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)benzo[d]thiazol-2-amine;

N-(Trans-3-(2-cyclopropyl-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)benzo[d]oxazol-2-amine;

N-(Trans-3-(2-cyclopropyl-3h-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)-1,7-naphthyridin-2-amine;

7-Chloro-N-(trans-3-(2-(tetrahydro-2H-pyran-4-yl)-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)quinoxalin-2-amine;

N-(Trans-3-(2-cyclopropyl-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)-1,7-naphthyridin-2-amine;

7-Chloro-N-(trans-3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)quinoxalin-2-amine;

7-Chloro-N-(trans-3-(2-cyclopropyl-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)quinolin-2-amine;

N-(Trans-3-(6-chloro-9H-purin-9-yl)cyclobutyl)quinazolin-2-amine;

N-(Trans-3-(3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)quinazolin -2-amine;

9-(Trans-3-(quinazolin-2-ylamino)cyclobutyl)-8-(trifluoromethyl)-9H-purin-6-ol;

N-(Trans-3-(6-morpholino-9H-purin-9-yl)cyclobutyl)quinazolin-2-amine;

Methyl 4-(9-(trans-3-(quinazolin-2-ylamino)cyclobutyl)-8-(trifluoromethyl)-9H-purin-6-yl)benzoate;

Methyl 4-(9-(trans-3-(quinazolin-2-ylamino)cyclobutyl)-9H -purin-6-yl)benzoate;

N-(Trans-3-(2-cyclopropyl-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)thiazolo[4,5-b]pyridin-2-amine;

7-Chloro-N-(trans-3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)quinazolin-2-amine;

1-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-3,3-dimethyl-1H-pyrrolo[2,3-b]pyridin-2(3H)-one;

1′-(Trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)spiro[cyclopropane-1,3′-pyrrolo[2,3-b]pyridin]-2′(1 ′H)-one;

1-(trans-3-((6-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-3,3-dimethyl-1H-pyrrolo[2,3-b]pyridin-2(3H)-one;

1′-(trans-3-(1,3-benzothiazol-2-ylamino)cyclobutyl)-5′-fluorospiro[cyclopropane-1,3′-pyrrolo[2,3-b]pyridin]-2′(1′H)-one;

5-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-7,7-dimethyl-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one;

1′-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)spiro[cyclobutane-1,3′-pyrrolo[2,3-b]pyridin]-2′(1′H)-one;

1′-(Trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)spiro[cyclopentane-1,3′-pyrrolo[2,3-b]pyridin]-2′(1′H)-one;

1′-(Trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-2,3,5,6-tetrahydrospiro[pyran-4,3′-pyrrolo[2,3-b]pyridin]-2′(1′H)-one;

1-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-1H-pyrrolo[2,3-b]pyridin-2(3H)-one;

1-(Cis-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-3,3-dimethyl-1H pyrrolo[2,3-b]pyridin-2(3H)-one;

3-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-1-cyclopropyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-6-fluoro-1-methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-1-cyclopropyl-6-fluoro-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-1-methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-1-cyclopentyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

1-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-3-cyclopropyl-1H-imidazo[4,5-b]pyrazin-2(3H)-one;

9-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-7-cyclopropyl-7H-purin-8(9H)-one;

3-(trans-3-((6-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

9-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-7-methyl-7H-purin-8(9H)-one;

3-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

1-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-3-methyl-1H-imidazo[4,5-b]pyrazin-2(3H)-one;

3-(trans-3-(quinolin-2-ylamino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

9-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-7H-purin-8(9H)-one;

3-(trans-3-((4-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-((5-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)oxazolo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-((7-fluoroquinolin-2-yl)amino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-(quinazolin-2-ylamino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(cis-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-((7-methoxyquinolin-2-yl)amino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(cis-3-(benzo[d]thiazol-2-yl(methyl)amino)cyclobutyl)-1-methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-((7-fluoroquinazolin-2-yl)amino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

N-(trans-3-(3-amino-1H-pyrazolo[3,4-b]pyridin-1-yl)cyclobutyl)benzo[d]thiazol-2-amine;

N-(trans-3-(3-cyclopropyl-1H-pyrazolo[3,4-b]pyridin-1-yl)cyclobutyl)benzo[d]thiazol-2-amine;

N-(trans-3-(3-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)cyclobutyl)benzo[d]thiazol-2-amine;

1-(4-((1-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)amino)piperidin-1-yl)ethanone;

N-(3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)-1,3-benzothiazol-2-amine;

1H-benzimidazol-2-yl(3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)methanol;

N-(cis-3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)-1,3-benzothiazol-2-amine;

N-(trans-3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)-1,3-benzothiazol-2-amine;

N-(trans-3-(2-methoxy-3H-imidazo[4,5-b]pyridin-3-yl)cyclobutyl)-3,4-dihydro-2-quinoxalinamine;

4-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one;

7,7-dimethyl-5-(trans-3-(thiazolo[5,4-b]pyridin-2-ylamino)cyclobutyl)-5h-pyrrolo[2,3-b]pyrazin-6(7h)-one;

3-(cis)-3-(benzo[d]thiazol-2-ylamino)cyclobutyl-1-methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-(benzo[d]oxazol-2-ylamino)cyclobutyl)-1-methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

3-(trans-3-((5-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-1-methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

1-methyl-3-(trans-3-((1-methyl-1H-benzo[d]imidazol-2-yl)oxy)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

1-methyl-3-(trans-3-((1-methyl-1H-benzo[d]imidazol-2-yl)amino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

7-(trans-3-(1,3-benzothiazol-2-ylamino)cyclobutyl)-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one;

5,5-dimethyl-7-(trans-3-(1,5-naphthyridin-2-ylamino)cyclobutyl)-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one;

3-(trans-3-((6-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-1-methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

5-(trans-3-((5-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-7,7-dimethyl-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one;

5-(trans-3-((5-fluoro-1,3-benzothiazol-2-yl)amino)cyclobutyl)-7,7-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

1-(trans-3-(1,3-benzothiazol-2-ylamino)cyclobutyl)-3-methyl-1,3-dihydro-2H-benzimidazol-2-one;

7-(trans-3-((6-fluoro-1,3-benzothiazol-2-yl)amino)cyclobutyl)-5,5-dimethyl-2-(methylsulfanyl)-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one;

7-(trans-3((6-fluoro-1,3-benzothiazol-2-yl)amino)cyclobutyl)-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one;

7,7-dimethyl-5-(trans-3-((1-methyl-1H-benzo[d]imidazol-2-yl)amino)cyclobutyl)-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one;

5-(trans-3-((1,8-naphthyridin-2-yl)amino)cyclobutyl)-7,7-dimethyl-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one;

5-(trans-3-((1,5-naphthyridin-2-yl)amino)cyclobutyl)-7,7-dimethyl-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one;

3,3-dimethyl-1-(trans-3-(2-quinazolinylamino)cyclobutyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one;

1-(trans-3-(1,3-benzoxazol-2-ylamino)cyclobutyl)-3,3-dimethyl -1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one;

5-(trans-3-((5,6-difluoro-1,3-benzothiazol-2-yl)amino)cyclobutyl)-7,7-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

5-(trans-3-((4,6-difluoro-1,3-benzothiazol-2-yl)amino)cyclobutyl)-7,7-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

5-(trans-3-((6-methoxy-1,3-benzothiazol-2-yl)amino)cyclobutyl)-7,7-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

7,7-dimethyl-5-(trans-3-([1,3]thiazolo[5,4-b]pyridin-2-ylamino)cyclobutyl)-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

1-methyl-3-(trans-3-([1,3]thiazolo[5,4-b]pyridin-2-ylamino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one;

1-cyclopropyl-3-(trans-3-((7-fluoro-2-quinazolinyl)amino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one;

5-(trans-3-((7-fluoro-2-quinazolinyl)amino)cyclobutyl)-7,7-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

1-cyclopropyl-3-(trans-3-((6-fluoro-1,3-benzoxazol-2-yl)amino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one;

5-(trans-3-((6-fluoro-1,3-benzoxazol-2-yl)amino)cyclobutyl)-7,7-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

1-cyclopropyl-3-(trans-3-([1,3]thiazolo[5,4-b]pyridin-2-ylamino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one;

1-cyclopropyl-3-(trans-3-((6-fluoro-1,3-benzothiazol-2-yl)amino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one;

(R)-1-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-3-hydroxy-3-methyl-1H-pyrrolo[2,3-b]pyridin-2(3H)-one;

(S)-1-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-3-hydroxy-3-methyl-1H-pyrrolo[2,3-b]pyridin-2(3H)-one;

(3R)-1-(trans-3-(1,3-benzothiazol-2-ylamino)cyclobutyl)-3-hydroxy-3-methyl-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one;

(3s)-1-(trans-3-(1,3-benzothiazol-2-ylamino)cyclobutyl)-3-hydroxy-3-methyl-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one;

1-cyclopropyl-3-(trans-3-(quinazolin-2-ylamino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

1-cyclopropyl-3-(trans-3-((5-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

1-cyclopropyl-3-(trans-3-((6-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

7,7-dimethyl-5-(3-(quinolin-2-ylamino)cyclobutyl)-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one;

7,7-dimethyl-5-(trans-3-(2-quinolinylamino)cyclobutyl)-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

5-(trans-3-((6-fluoro-2-quinolinyl)amino)cyclobutyl)-7,7-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

5-(trans-3-((7-fluoro-2-quinolinyl)amino)cyclobutyl)-7,7-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

5-(trans-3-(1,3-benzothiazol-2-yloxy)cyclobutyl)-7,7-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-b]pyrazin-6-one;

6-fluoro-1-methyl-3-(trans-3-(quinazolin-2-ylamino)cyclobutyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;

1-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-3,3,5-trifluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one;

6-fluoro-3-(trans-3-((6-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-1-methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

6-fluoro-3-(trans-3-((5-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-1-methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one;

1-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-5-chloro-3,3-difluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one;

1-(trans-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-3,3-difluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one;

1-cyclopropyl-3-(trans-3((6-fluorobenzo[d]thiazol-2-yl)amino)cyclobutyl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one;

1-(trans-3-(1,3-benzothiazol-2-ylamino)cyclobutyl)-3,3-difluoro-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one;

5-(cis-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-7,7-dimethyl-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one;

1-(cis-3-(benzo[d]thiazol-2-ylamino)cyclobutyl)-3-methyl-1H-imidazo[4,5-b]pyrazin-2(3H)-one;

n-(cis-3-(7,7-dimethyl-6-oxo-6,7-dihydro-5H-pyrrolo[2,3-b]pyrazin-5-yl)cyclobutyl)-1H-benzo[d]imidazole-2-carboxamide;

1-cyclopropyl-3-(trans-3-(quinazolin-2-ylamino)cyclobutyl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one;

1-(trans-3-(benzo[d]oxazol-2-ylamino)cyclobutyl)-3-cyclopropyl-1H-imidazo[4,5-b]pyrazin-2(3H)-one;

1-cyclopropyl-3-(trans-3-((5-fluoro-1,3-benzothiazol-2-yl)amino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one;

1-cyclopropyl-3-(trans-3-(1,8-naphthyridin-2-ylamino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one;

1-cyclopropyl-3-(trans-3-((6-methoxy-1,3-benzothiazol-2-yl)amino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one;

1-cyclopropyl-3-(trans-3-(2-quinolinylamino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one;

1-cyclopropyl-3-(trans-3-((1-methyl-1H-benzimidazol-2-yl)amino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one;

1-(trans-3-((6-chlorobenzo[d]oxazol-2-yl)amino)cyclobutyl)-3-cyclopropyl-1H-imidazo[4,5-b]pyrazin-2(3H)-one;

1-(trans-3-(1,3-benzothiazol-2-ylamino)cyclobutyl)-5-bromo-3-cyclopropyl-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one; and

5-bromo-3-cyclopropyl-1-(trans-3-((7-fluoro-2-quinazolinyl)amino)cyclobutyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2014
From: ALLEN, JENNIFER R.; AMEGADZIE, ALBERT; ANDREWS, KRISTIN L.; BROWN, JAMES; CHEN, JIAN J.; CHEN, NING; HARRINGTON, ESSA HU; LIU, QINGYIAN; NGUYEN, THOMAS T.; PICKRELL, ALEXANDER J.; QIAN, WENYUAN; RUMFELT, SHANNON; RZASA, ROBERT M.; YUAN, CHESTER CHENGUANG; ZHONG, WENGE
To: AMGEN INC.
Reel/Frame 032020/0248 →
Continuity (2)
Provisional Application 61605148 · Feb 29, 2012
Related Publication 20130225552A1 · Aug 29, 2013